Updated: 12/21/2019

Antianginal Drugs

0%
Topic
Review Topic
0
0
0%
0%
Evidence
4 4
0
0
Snapshot
  • A 54-year-old man presents to the emergency department after experiencing pressure-like sternal chest pain that radiates down the left arm. Medical history is significant for hypertension, hypercholesterolemia, and type II diabetes. He smokes 2 packs of cigarettes per day for the past 25 years. On physical exam, the patient appears anxious and diaphoretic. An electrocardiogram demonstrates an ST-segment elevation in leads V1-V4. Cardiac troponins are sent. He is given aspirin, nitroglycerin, metoprolol, clopidogrel, and unfractionated heparin. The cardiac catheterization lab is activated .
Introduction
  • Appropriate treatment for acute coronary syndrome must be instituted immediately in order to
    • limit myocardial damage
    • decrease the risk of complications
    • restore the balance between myocardial oxygen supply and demand
NSTEMI and Unstable Angina (UA)
  • Introduction
    • NSTEMI and UA are managed in the same manner
    • the goal is to to provide 
      • anti-ischemic therapy
        • restores the myocardial oxygen supply and demand
      • anti-thrombotic therapy
        • prevents further growth of the partial thrombotic occlusion
  • Medications
    • anti-ischemic therapy
      • β-blockers (e.g., metoprolol)
        • mechanism
          • decreased sympathetic drive to the heart
            • promotes myocardial electrical stability
            • decreases myocardial demand
            • ↓ cAMP
          • improves mortality in patients with an MI
        • contraindications
          • bronchospasm
          • decompensated heart failure
          • hypotension
      • nitrates (e.g., nitroglycerin, isosorbide mononitrate, and dinitrate)
        • mechanism 
          • venodilation reduces preload to the heart, which reduces myocardial demand
            • recall that a reduction in preload reduces ventricular wall stress
          • afterload reduction and decreased SVR
          • coronary artery dilation improves blood flow to the myocardium
            • recall that venodilation >> arterial dilation
            • this can steal blood from already maximally dilated ischemic myocardium 
          • ↑ cGMP 
        • adverse events
          • nitroprusside causes cyanide toxicity
          • development of tolerance for the vasodilating action during the work week
          • a headache may result from vasodilation of cerebral arteries
          • can results in hypotension when combined with other blood pressure lowering medications
      • calcium channel blockers (e.g., verapamil and diltiazem)
        • mechanism
          • reduces heart rate and cardiac contractility
          • this medication is reserved for patients unresponsive to β-blockers and nitrates or have contraindications to β-blockers
            • this is because calcium channel blockers do not provide a mortality benefit
    • anti-thrombotic therapy
      • aspirin
        • mechanism
          • an inhibitor of thromboxane A2 synthesis 
            • thromboxane A2 is a prominent promoter of platelet activation
          • improves mortality and should be continued indefinitely
      •  P2Y12 ADP receptor inhibitor (e.g., clopidogrel and ticagrelor)
        • mechanism
          • prevents ADP from binding to the P2Y12 receptor, which would normally further activate platelets
    • anti-coagulation therapy
      • unfractionated heparin
        • mechanism
          • binds to antithrombin to enhance its effects
          • inhibits factor Xa
ST-Segment Elevation Myocardial Infarction (STEMI)
  • Introduction
    • STEMI suggest that there is a total occlusion of the vessel
      • thus the main goal is to induce rapid reperfusion via
        • percutaneous coronary intervention (PCI) OR
        • fibrinolytic therapy
      • patients are also given medications such as those used in NSTEMI and UA
        • aspirin
        • unfractionated heparin
        • β-blockers
        • nitrates
        • P2Y12 ADP receptor inhibitor 
  • Reperfusion therapy
    • primary PCI
      • the preferred method for reperfusion
      • must be performed within 90 minutes of first medical contact
        • aspirin and a P2Y12 receptor inhibitor is given prior to the procedure
    • fibrinolytic therapy (e.g., alteplase)
      • performed if PCI cannot be performed within 90 minutes or is unavailable
      • fibrinolytics convert plasminogen to plasmin, which degrades newly formed clots
Adjunctive Therapy
  • Angiotensin-converting enzyme (ACE) inhibitors (e.g., lisinopril)
    • provides a mortality benefit
    • prevents ventricular cardiac remodeling and reduces the rate of heart failure
  • Statins (e.g., atorvastatin) 
    • an HMG-CoA reductase inhibitor that lowers cholesterol levels
Therapy And Their Effect On Mortality
 
Effect on Mortality of Therapy Used in Acute Coronary Syndromes
Mortality Benefit
No Mortality Benefit
  • Aspirin
  • β-blockers
  • PCI
  • Statins
  • P2Y12 ADP receptor inhibitor 
  • Thrombolytics
  • Oxygen
  • Morphine
  • Nitrates
  • Calcium channel blockers
  • Lidocaine
  • Amiodarone
 
 

Please rate topic.

Average 5.0 of 1 Ratings

Thank you for rating! Please vote below and help us build the most advanced adaptive learning platform in medicine

The complexity of this topic is appropriate for?
How important is this topic for board examinations?
How important is this topic for clinical practice?
Evidences (4)
Topic COMMENTS (4)
Private Note